© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Take a moment to consider the journey of the humble 2-chloromethyl-3-methyl-4-methoxypyridine. Chemistry doesn’t always get a flashy spotlight, but in the pharmaceutical world, these building blocks shape entire treatment landscapes. Not so long ago, the search for stronger, more stable medications for stomach acid led researchers to proton pump inhibitors. Pantoprazole, now a household name in gastroenterology, leans heavily on its upstream intermediates. The evolution from basic pyridine chemistry to the specific forms needed for these drugs showcases the ingenuity of synthetic chemists. Over time, they developed selective processes that improved yields and purity, key for supporting the consistent quality people expect from medicines. Each innovation in this area has reflected a broader shift towards tighter quality standards, spurred by increasing regulation and better analytical tools that can root out impurities.
2-Chloromethyl-3-methyl-4-methoxypyridine, sometimes referenced in lab circles under various synonyms, acts as a crucial intermediate during pantoprazole synthesis. Unlike some specialty chemicals with narrow use-cases, this molecule’s recurring role sits at a crossroads between raw materials and clinically useful compounds. I’ve seen it take center stage during synthesis runs, always under close monitoring because any deviation in purity or reactivity echoes throughout downstream processes. Stepping into most production facilities, you’ll see carefully labeled containers, reminders of the care inherent to handling pharmaceutical intermediates that influence patient outcomes. The molecule itself, modest in appearance, really underlines how modern medicine’s leaps depend on small chemical updates.
This compound does not draw attention in everyday language, but its properties make it more than a mere bench chemical. 2-Chloromethyl-3-methyl-4-methoxypyridine tends to present itself as a pale to slightly yellow viscous liquid or crystalline solid, depending on the conditions. Its relatively low melting point and good solubility in organic solvents make it practical for large-scale reactions. What the textbooks don’t always highlight is how its chemical stability and selective reactivity empower the precise attachment of functional groups. Tinkering with its structure takes skill; small miscalculations in temperature, solvent, or timing can spoil expensive batches and send chemists back to square one.
Quality standards for this compound have only grown more stringent over the years. Direct experience in production lines underscores how each shipment requires certificates detailing assay, purity, and potential impurities. Mislabeling or failing to catch trace halide contamination in this compound spells trouble for anyone trying to achieve compliance with regulatory filings. Analytical standards like HPLC, NMR, and mass spectrometry reports get stapled to every batch, with archiving procedures reminding us that a single error years ago might prompt recalls or regulatory headaches today. This degree of documentation protects everyone—from the chemist to the patient.
The synthetic routes for 2-chloromethyl-3-methyl-4-methoxypyridine reflect the constant drive for greater efficiency and safety. Traditional methods often start with a functionalized pyridine ring, introducing the chloromethyl moiety under tightly controlled conditions using chlorinating agents. Over time, many labs have moved toward greener alternatives and more efficient catalysts, since each improvement saves resources and lessens environmental load. Even after years working with these substances, the careful preparation always feels nerve-wracking, since high-energy steps and hazardous reagents demand full attention to avoid accidents and maximize yield.
Handling this intermediate reminds me how much fine-tuning chemistry impacts pharmaceutical outcomes. The molecule’s halogen and methoxy substituents turn it into an ideal platform for subsequent nucleophilic substitution reactions, driving the assembly of pantoprazole’s distinctive benzimidazole ring system. Each modification step must balance selectivity, yield, and potential rearrangements. Side reactions never stick to theory, so process development teams tweak parameters constantly. Post-synthesis, analysts scrutinize samples for byproducts, since regulatory scrutiny doubles any time new impurities turn up. Iterative improvement in these steps keeps costs down and assures doctors their prescriptions come from predictable sources.
A walk through any chemical database quickly reveals the many faces of 2-chloromethyl-3-methyl-4-methoxypyridine. It sometimes crops up under code numbers, sometimes as a methyl-methoxy pyridine derivative, and other times via naming conventions specific to patent filings. For those of us in the trenches, this regulatory alphabet soup occasionally leads to confusion and paperwork headaches, especially when comparing global supplier catalogs. Such confusion reinforces the need for up-to-date documentation and regular supplier communication to avoid mix-ups that can delay production.
Safe handling of this intermediate requires vigilance every step of the way. Direct exposure to alkyl chlorides like this one can bring health hazards, from skin irritation to more significant long-term effects. Down-to-earth, I always felt more comfortable knowing that everyone in the lab wore full PPE and treated volatile reagents with the respect they deserve. Ventilation systems, spill containment materials, and emergency eye-wash stations should never be outdated or overlooked. Regulatory agencies worldwide back up these concerns, as lapses in GMP (Good Manufacturing Practice) standards not only threaten worker safety but also product credibility. Training staff and making safety culture a routine conversation takes real effort but pays dividends in both lower accident rates and peace of mind.
Everyone familiar with the world of pharmaceuticals knows that intermediates like this drive the efficiency and reliability of drug synthesis. The main story for 2-chloromethyl-3-methyl-4-methoxypyridine is pantoprazole and its relatives. The scale of demand here isn’t small. Hospitals, clinics, and pharmacies worldwide all depend on the steady flow of high-purity intermediates to keep their supply chains healthy. Whether it’s a generic factory or a research-scale facility, the difference boils down to batch size rather than expectations for quality or reliability. Other applications remain mostly speculative, with the compound rarely leaving its pharmaceutical niche.
Each year brings small improvements in synthetic technique, purification, and waste reduction around pyridine intermediates. Teams of chemists and engineers run experiments to test stronger catalysts, easier extraction protocols, and ways to recycle waste streams. In R&D, even minor improvements echo through thousands of production runs. Advancements in process automation have made oversight easier, letting fewer people run more reactions while still catching problems before they balloon. As more governmental agencies demand lifecycle assessments of pharmaceutical ingredients, labs end up customizing new pathways to less-polluting, more cost-effective synthesis. R&D never feels static here; the field shifts constantly in response to both economic and regulatory pressure.
Toxicity data around this intermediate has grown richer as more is produced and handled. Like most chlorinated organic compounds, risk management dominates discussions. Direct ingestion or inhalation poses documented hazards, and data from animal testing reinforces the importance of containment and waste cleanup. Frequent reviews of Material Safety Data Sheets by technicians go beyond red tape—staying aware of the newest toxicology findings helps build a safer workplace. Industrial hygiene groups increasingly press for better monitoring equipment and exposure limits, so operational standards can keep pace with evolving science. It’s not just about compliance; accidents and exposures linger in people’s memories for years.
Looking ahead, the outlook for 2-chloromethyl-3-methyl-4-methoxypyridine follows the fortunes of pantoprazole and similar drugs. As regulatory bodies grow even stricter, the pharmaceutical world demands even purer materials and more environmentally conscious manufacturing routes. Newer analytical tools promise even deeper scrutiny of impurities, making robust quality systems more valuable. Process chemists keep searching for ways to cut steps, reuse solvents, and minimize hazardous waste while still hitting price points demanded by healthcare systems. Eventually, competition from alternative drug classes or shifts in treatment guidelines may reduce demand, but that day remains a distant worry for now. If anything, the compound’s journey—from chemical curiosity to industrial workhorse—testifies to the cycles of innovation, regulation, and adaptation that define pharmaceutical chemistry.
2-Chloromethyl-3-methyl-4-methoxypyridine doesn’t turn many heads outside the pharmaceutical lab, but it plays a key part in making Pantoprazole Sodium, a widely-used anti-ulcer drug. Purity standards here are far from trivial. People depend on reliable medicine, and those links all start with the building blocks. That’s why each chemical in the process must meet serious scrutiny.
I’ve seen some variations in specifications over the years, depending on country regulations and end-use requirements. For this intermediate, reputable suppliers lock their purity levels at 98% or above, sometimes stretching to 99%. The remaining percentage covers trace solvents, moisture, related substances, or process-specific impurities. Going any lower can threaten the final drug’s stability or lead to off-target byproducts during synthesis. Many pharmaceutical quality teams zero in on those numbers through high-performance liquid chromatography (HPLC) and gas chromatography (GC), often run alongside NMR analysis for identity.
Every impure batch risks pushing unknowns further down the chemical chain. For a drug like Pantoprazole Sodium, which millions of vulnerable patients take, those unknowns can’t be shrugged off. Impurity profiles matter not just for safety, but for compliance. Regulatory guidelines from the ICH (International Council for Harmonisation) cap individual impurities below 0.5% and total impurities often under 2%. In my experience, regulatory inspections can hinge on showing comprehensive impurity control data, backed by strong documentation.
Setting a purity bar in specifications isn’t enough. Testing must run batch-after-batch and across every supplier change. Cross-validation between labs makes sense, too. When I worked with pharmaceutical clients, any new supplier or analytical method triggered a full round of qualification. Chromatographic fingerprints, reference standards, and retention time verification all become regular topics among the technical team. In practice, supply chain consistency stands only as strong as the weakest analytical method.
Process control often poses the biggest challenge. Minor batch temperature swings or slightly off stoichiometry in earlier steps can spike impurity formation. I’ve watched experienced chemists fuss over solvent quality or glassware cleanliness because minor lapse can unbalance the reaction. Synthetic yield sometimes gets pushed higher at the cost of more side products, making tight purification a must. Real transparency between chemical suppliers and buyers makes troubleshooting much easier, but shortcuts or vague reporting can stall root cause analysis.
Real improvements often come from robust supplier qualification programs and investment in in-house analytical capabilities. Companies benefit from sharing impurity profiling data openly with their vendor base. Regular audits and technical exchanges make costly surprises less likely. I tell teams to invest in both process analytics and training, not just equipment upgrades. Over time, this builds credibility with auditors and reduces the stress of surprise investigations.
Every patient trust starts upstream, right at the stage of pure intermediates. Even for a compound many never see or pronounce, purity sets the tone for downstream safety and compliance. Market leaders don’t settle for just barely passing marks; they focus on depth of analysis, tight specifications, and good communication within their supplier networks. That culture is what keeps lives safer, drug recalls lower, and confidence higher.
People often overlook storage, especially when juggling deadlines or shipment schedules. But a lot of trouble starts with sloppy storage, especially for intermediates that play a role in making medicines, chemicals, or even flavors. I’ve seen a few cases where folks push aside guidance and end up with yellowed powder, odd smells, or lost lots. Most intermediates come with their own quirks: moisture sensitivity, temperature limits, or the urge to react if left exposed. Based on well-documented industry experience, dry and cool holds real weight. High heat or humidity can speed up unwanted reactions, especially when an intermediate carries moisture-loving groups or fine particles.
The U.S. Pharmacopeia and FDA both recommend controls that make stability real—not just a compliance box. For example, controlling temperature at 2–8°C (refrigerator range) is a frequent demand if an intermediate looks likely to decompose above room temperature. If you want a number, most intermediates keep best below 25°C, sealed with desiccant in airtight containers. Some, though, go further and call for storage under nitrogen, blocking both air and water vapor. And if you ever see haze or clumping, that’s often already a sign the temperature or humidity jumped out of range.
Mistakes seldom come from a single point of failure—they usually pile up. Maybe containers get opened too often, left uncapped on a crowded bench, or stuffed in a hot warehouse. I’ve witnessed labs lose material simply because someone skipped mounting a humidity gauge or assumed a storeroom’s AC handled it all. Many facilities still don’t use proper monitoring or logbooks. One slip with an intermediate that’s moisture-sensitive sends both yield and purity down the drain.
Common practice—and science—show moisture turns some powders tacky or causes them to break down into byproducts. Others might oxidize, forming colored impurities you don’t want. Good labeling helps, but real action means physical controls: sealed drums, humidity packets, and regular checks. Electronic data loggers beat old pencils and charts because they catch trouble early. In my experience, sites with alarms for shifting temperature or spikes in humidity save batches that might have been ruined by a weekend power cut.
Strong storage starts with the right gear. Airtight jars or drums, preferably lined with food-grade plastic or tested metal, slam the door on most intruders. Pallets keep material off damp floors, while racking systems avoid stacking that crushes packaging. Temperature control is usually best managed with climate-controlled rooms, not just a single old fridge in the corner. For those dealing with dozens of intermediates daily, digital records tracking batch movements and conditions can give quick insights—no more searching handwritten notes for mysteries.
Training counts too. Each year, I’ve seen new hires helped most by real-world drills—what to do if humidity spikes, who to call if the freezer fails, how to seal a barrel properly. Manufacturers benefit from sharing incidents and fixes, building a culture where storage isn’t an afterthought. Any lab or plant that sets up routine checks—weekly or even daily—stays miles ahead of rot, clumping, or contamination.
The safest path means treating an intermediate with as much respect as the finished product. Good storage isn’t just about rules, but about making sure materials arrive at the next step exactly as expected. Bad storage decisions cost time, money, and sometimes safety. Following recommended temperature, humidity, and containment gives every batch the best shot at reliability and purity.
If you’ve ever found yourself standing in an aisle or picking a product out of an online catalog, you probably noticed how sizing runs the gamut from small packets to large sacks. Businesses set these package sizes based on what works for homes, workshops, or even commercial outfits. Large packaging saves on frequent reordering, but not everyone wants to lift a 50-pound bag—sometimes you just need a handful. Across my years working with suppliers, delivery drivers, and even family members running small businesses, the question of “how much is in the bag?” pops up just as often as what’s inside.
In the grocery world, products commonly show up in single-use sachets—think of 5-gram, 10-gram, and up to 100-gram packets. These are popular at checkout lines when you need something for one meal or a recipe. Kitchens stock them for easy access or to keep things fresh. I’ve seen people hesitate to buy bigger containers because they worry about spoilage or clutter. Brands offer these smaller packets for that reason.
Step up a bit, and supermarkets tend to carry larger sizes like 250 grams, 500 grams, or 1 kilogram tubs or pouches. Most families gravitate to these medium packages because they last for weeks but won’t eat up all your pantry space. These sizes sit between value and convenience. I’ve heard plenty of people say that a kilo feels like a sensible commitment—you’ll get through it before it feels stale, but you’re not stocking up like a restaurant.
For restaurants, catering companies, and folks who run bakeries or food stalls, bulk packaging keeps costs down. I’m talking sacks of 5 kilograms, 10 kilograms, 25 kilograms, and sometimes even hefty 50-kilo bags. These sizes can be daunting at first sight, but you cannot beat the economics. According to 2023 data from the Packaging Industry Association, bulk sizes make up about a third of total product volume sold worldwide—proof that bigger packages aren’t only for factories or industrial kitchens.
Some businesses request custom intermediate sizes, like 2 kilograms or 5-pound jugs, especially if they're distributing to smaller outlets or want tighter control over inventory. This customization serves a practical need—enough material on hand without sinking cash into surplus stock or risking spoilage.
Size selection shapes a product’s carbon footprint. Bigger formats mean fewer trips to the store, less packaging waste, and often lower costs per unit. A single-serve packet may generate convenience, but it leaves behind more wrappers and adds up in the landfill. In recent years, eco-conscious shoppers push brands to offer bulk and refill options. According to a 2022 consumer study, 41% of buyers would “often or always” pick a larger size or refill package over several small packs, if given the choice.
Local rules matter, especially for food items or chemicals—laws may set caps or minimums for public safety. Handling ease comes into play too; weight limits for lifting, rules around shelf stacking, and storage needs can drive a shift toward smaller packs for some products. My own preference depends on kitchen space: in a small city apartment, jumbo containers crowd out everything else, so I stick to middle-of-the-road tubs.
Manufacturers meet these challenges with smarter packaging, offering resealable bags, sturdy tubs, or eco-friendly wraps in multiple weights. Some stores let shoppers bring their own containers. The packaging world will keep reinventing itself so that people can match size to actual need—without all the waste.
Anyone who’s ever worked with chemicals, tools, or heavy equipment learns quick lessons about respect. Early in my career, I put gloves on because someone told me, not because I understood the reason. I soon found out why after a brush with an acidic cleaner. Even a moment’s carelessness led to redness, discomfort, and an unforgettable reminder: safety habits are more than red tape. They protect what’s irreplaceable—our health.
Picking up a clipboard or turning a valve without checking the label may seem harmless. Yet hidden dangers often lurk in the everyday. The American National Safety Council reports thousands of eye injuries result from simple lapses—no goggles, no quick inspection before starting a job. Substances might splash. Fumes might cause trouble. Labels, safety data sheets, and training classes lay out risks in plain terms. Taking time to review this information gives us a fighting chance against avoidable accidents. Growing up, I ignored plenty of warnings, thinking nothing serious would happen. One friend spent a night in the ER after mixing bleach and ammonia. That story stuck with me. Sometimes, the lesson is not worth learning the hard way.
All too often, we see news stories about accidents that didn't have to happen. Many boil down to skipped steps: no gloves when handling solvents, open-toed shoes in crowded workshops, food or drinks near spills, or leaving containers uncapped. The Centers for Disease Control and Prevention highlight that most chemical exposures come down to routine shortcuts, not freak events. Even making sure to wash up before eating or calling it a day keeps invisible contamination away from mouths and eyes.
Chemicals and machinery should stay in properly labeled, sturdy containers. Use the right tools for the task—improvised solutions often backfire. Keep hands away from faces and always have a spill kit handy wherever substances are handled. Emergency showers and eyewash stations sound like overkill until the day you reach for one. There's no substitute for being prepared. In jobs that involve dust, fumes, or particles, a well-fitted respirator keeps harmful substances from sneaking into lungs. Mask fit testing isn’t just bureaucracy; it’s personal insurance.
New staff sometimes see safety training as a chore. Skipping it means confusion when alarms sound, accidents unfold, or someone needs speedy first aid. I’ve watched seasoned workers practice broken-routine drills, and their confidence during emergencies stands out. Refresher courses keep everyone alert to changing risks as materials or procedures change. Open communication in teams ensures someone will say something if they spot a missing sign or a leaky container. Fixing small issues before they grow prevents tragedy.
Creating safe places takes more than checklists. It grows from a clear expectation that shortcuts have no place and reporting concerns won’t lead to trouble. Managers lead by example and listen to suggestions about safer equipment or better layouts. Upgrades to ventilation or personal protective gear answer real needs, not just regulations. Regular audits and open conversations help spot blind spots or creeping complacency. By weaving safety into every shift, we set the standard that everyone goes home as healthy as they arrived. That is worth every extra minute spent checking, double-checking, and speaking up.
Folks in the labs and warehouses know the drill. You’ve finished sourcing a crucial chemical intermediate—something that sits between raw materials and finished products. Just as the order goes through, the email lands: “Can you provide the COA and MSDS for this intermediate?” For anyone who’s spent time in chemical distribution, these acronyms shape your day.
A Certificate of Analysis (COA) spells out whether a batch meets its specifications. I remember opening a shipment of a simple solvent years ago and finding the COA didn’t match the lot number. We had deadlines, but using that material could have risked the whole process. That’s the reason people insist on checking COAs before anything moves into production. It’s not a hoop to jump through—it’s the difference between quality assurance and a costly recall.
Regulatory bodies scrutinize every detail in certain industries. Take pharmaceuticals as an example. A COA that falls short doesn’t just delay timelines. It can trigger inspections or fines. FDA warning letters often cite documentation gaps, so one missing certificate slides easily into an expensive compliance headache.
Material Safety Data Sheets (MSDS) used to live in dusty folders near the storage room. Over time, I learned they belong within arm’s reach because accidents aren’t picky about time or place. The MSDS tells more than safe handling—there’s toxicity data, ventilation advice, and emergency measures if a spill turns dangerous. I’ve seen busy production floors where quick access to these sheets let operators avoid real harm when a bottle shattered mid-shift.
Governments don’t leave this to chance. In the United States, OSHA enforces rules around right-to-know standards. Sites caught without accessible MSDS risk heavy penalties. Workers and supervisors both need clear data before they start combining or reacting anything unfamiliar.
Requests for COA and MSDS pop up for a reason, yet gaps still appear. Sometimes suppliers miss updates when formulations shift. Global supply chains often stretch from regions with different documentation standards, so files arrive incomplete or use unexpected formats. I’ve spent hours chasing paper trails for imported materials because the original manufacturer didn’t translate the documentation as required by US regulations.
Language, version, and lot number mismatches are common headaches. Many organizations keep a digital library but depend too much on assumptions that the last update is current. Industries hold up shipments for a missing MSDS because they don’t get a green light from safety review until every detail is correct.
Building strong relationships with suppliers makes a difference. Signing contracts that spell out documentary requirements brings clarity from the start. Regular audits—both in-person and virtual—keep everyone honest about paperwork standards.
Technology helps. My last company rolled out an automated COA and MSDS request system. As soon as we keyed in a purchase order, the request went straight to the supplier, and the files attached to the item’s digital record. It did not eliminate all headaches, but it cut down last-minute scrambles.
At the end of the day, solid documentation protects more than compliance; it shields workers, customers, and company reputation. Pushing for every batch’s COA and MSDS isn’t red tape. It's just common sense.
| Names | |
| Preferred IUPAC name | 2-(Chloromethyl)-3-methyl-4-methoxypyridine |
| Other names |
2-Chloromethyl-3-methyl-4-methoxypyridine Pantoprazole Intermediate Pantoprazole Sodium Intermediate 2-(Chloromethyl)-3-methyl-4-methoxypyridine CAS 151060-54-7 |
| Pronunciation | /tuː-klɔːr.oʊˌmɛθ.ɪl-θriː-ˈmɛθ.ɪl-foʊr-mɛˌθɒk.si-pɪˈrɪˌdiːn/ |
| Identifiers | |
| CAS Number | [94050-90-9] |
| 3D model (JSmol) | `3D model (JSmol)` string for **2-Chloromethyl-3-Methyl-4-Methoxypyridine**: ``` CC1=C(OC)C=CN=C1CCl ``` This is the **SMILES** string representation, which you can use to generate a 3D model in JSmol or similar viewers. |
| Beilstein Reference | 83827 |
| ChEBI | CHEBI:131964 |
| ChEMBL | CHEMBL159148 |
| ChemSpider | 23876521 |
| DrugBank | DB00213 |
| ECHA InfoCard | 03be2b80-edc8-4052-9181-d1870a28a2cd |
| Gmelin Reference | **Gmelin Reference: 82338** |
| KEGG | C19209 |
| MeSH | D017676 |
| PubChem CID | 11910416 |
| RTECS number | GV8134000 |
| UNII | 24RJ7E02DQ |
| UN number | UN3276 |
| CompTox Dashboard (EPA) | DTXSID3047351 |
| Properties | |
| Chemical formula | C8H10ClNO |
| Molar mass | 157.61 g/mol |
| Appearance | White to off-white solid |
| Odor | Odorless |
| Density | 1.18 g/cm3 |
| Solubility in water | Insoluble in water |
| log P | 1.6 |
| Vapor pressure | 1.78E-02 hPa at 25 °C |
| Acidity (pKa) | pKa = 4.13 |
| Basicity (pKb) | 4.09 |
| Refractive index (nD) | 1.533 |
| Dipole moment | 3.73 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 369.23 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -67.8 kJ/mol |
| Pharmacology | |
| ATC code | A02BC02 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation. |
| GHS labelling | GHS05, GHS07 |
| Pictograms | GHS05,GHS07 |
| Signal word | Danger |
| Hazard statements | H301 + H311 + H331: Toxic if swallowed, in contact with skin or if inhaled. |
| Precautionary statements | P261, P264, P271, P272, P273, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P333+P313, P362+P364, P403+P233, P405, P501 |
| NFPA 704 (fire diamond) | 2-3-1-W |
| Flash point | 74.2 °C |
| Autoignition temperature | 120°C |
| LD50 (median dose) | LD50 (median dose): Rat oral >2000 mg/kg |
| NIOSH | Not Listed |
| PEL (Permissible) | PEL (Permissible Exposure Limit) for 2-Chloromethyl-3-Methyl-4-Methoxypyridine (Pantoprazole Sodium Intermediate): Not established |
| REL (Recommended) | REL: Not established |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
Pantoprazole Pantoprazole Sodium Pantoprazole Sulfide Pantoprazole Sulfone 2-Methyl-3-methoxy-4-aminopyridine 2-Chloromethyl-3,4-dimethoxypyridine |
